{"count": 7, "results": [{"_id": "32676702", "pmid": 32676702, "pmcid": "PMC7591415", "title": "Identification of an oral microbiota signature associated with an impaired orosensory perception of lipids in insulin-resistant patients", "journal": "Acta Diabetol", "authors": ["Besnard P", "Christensen JE", "Bernard A", "Simoneau-Robin I", "Collet X", "Verges B", "Burcelin R"], "date": "2020-12-01T00:00:00Z", "doi": "10.1007/s00592-020-01567-9", "meta_date_publication": "2020 Dec", "meta_volume": "57", "meta_issue": "12", "meta_pages": "1445-1451", "score": 50237.074, "text_hl": "Surprisingly, a lower @<m>DISEASE_Lipoma</m> @DISEASE_MESH:D008067 @@@fatty@@@ taste perception was mainly found in @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and/or statins, suggesting a possible side effect of these antidiabetic and/or hypolipidemic drugs on taste acuity.", "citations": {"NLM": "Besnard P, Christensen JE, Bernard A, Simoneau-Robin I, Collet X, Verges B, Burcelin R. Identification of an oral microbiota signature associated with an impaired orosensory perception of lipids in insulin-resistant patients Acta Diabetol. 2020 Dec;57(12):1445-1451. PMID: 32676702", "BibTeX": "@article{32676702, title={Identification of an oral microbiota signature associated with an impaired orosensory perception of lipids in insulin-resistant patients}, author={Besnard P and Christensen JE and Bernard A and Simoneau-Robin I and Collet X and Verges B and Burcelin R}, journal={Acta Diabetol}, volume={57}, number={12}, pages={1445-1451}}"}}, {"_id": "29643297", "pmid": 29643297, "pmcid": "PMC6021872", "title": "Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model", "journal": "J Vet Med Sci", "authors": ["Toriniwa Y", "Saito T", "Miyajima K", "Ishii Y", "Uno K", "Maekawa T", "Matsui T", "Kume S", "Yamada T", "Ohta T"], "date": "2018-06-06T00:00:00Z", "doi": "10.1292/jvms.18-0119", "meta_date_publication": "2018 Jun 6", "meta_volume": "80", "meta_issue": "6", "meta_pages": "878-885", "score": 50049.53, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment significantly inhibited the @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ in SDT @<m>DISEASE_Lipoma</m> @DISEASE_MESH:D008067 @@@fatty@@@ @SPECIES_10116 @@@rats@@@ fed a @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@-enriched diet; however, the pharmacological potential to improve @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NASH@@@-like lesions is mild when compared with @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@ treatment. ", "citations": {"NLM": "Toriniwa Y, Saito T, Miyajima K, Ishii Y, Uno K, Maekawa T, Matsui T, Kume S, Yamada T, Ohta T. Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model J Vet Med Sci. 2018 Jun 6;80(6):878-885. PMID: 29643297", "BibTeX": "@article{29643297, title={Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model}, author={Toriniwa Y and Saito T and Miyajima K and Ishii Y and Uno K and Maekawa T and Matsui T and Kume S and Yamada T and Ohta T}, journal={J Vet Med Sci}, volume={80}, number={6}, pages={878-885}}"}}, {"_id": "33435021", "pmid": 33435021, "title": "Establishment of an ex Vivo Model of Nonalcoholic Fatty Liver Disease Using a Tissue-Engineered Liver.", "journal": "ACS Biomater Sci Eng", "authors": ["Wu Q", "Liu J", "Liu L", "Chen Y", "Wang J", "Leng L", "Yu Q", "Duan Z", "Wang Y"], "date": "2018-08-13T00:00:00Z", "doi": "10.1021/acsbiomaterials.8b00652", "meta_date_publication": "2018 Aug 13", "meta_volume": "4", "meta_issue": "8", "meta_pages": "3016-3026", "score": 50048.105, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment of the @<m>DISEASE_Lipoma</m> @DISEASE_MESH:D008067 @@@TEF@@@ @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver@@@ model caused reduced cellular @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglycerides@@@, activated @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ molecule, inhibited mTORC1 signaling pathway, which thus affected the synthesis and metabolism of @CHEMICAL_Fatty_Acids_Nonesterified @CHEMICAL_MESH:D005230 @@@FFAs@@@. ", "citations": {"NLM": "Wu Q, Liu J, Liu L, Chen Y, Wang J, Leng L, Yu Q, Duan Z, Wang Y. Establishment of an ex Vivo Model of Nonalcoholic Fatty Liver Disease Using a Tissue-Engineered Liver. ACS Biomater Sci Eng. 2018 Aug 13;4(8):3016-3026. PMID: 33435021", "BibTeX": "@article{33435021, title={Establishment of an ex Vivo Model of Nonalcoholic Fatty Liver Disease Using a Tissue-Engineered Liver.}, author={Wu Q and Liu J and Liu L and Chen Y and Wang J and Leng L and Yu Q and Duan Z and Wang Y}, journal={ACS Biomater Sci Eng}, volume={4}, number={8}, pages={3016-3026}}"}}, {"_id": "16796890", "pmid": 16796890, "title": "[Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].", "journal": "Zhonghua Yi Xue Za Zhi", "authors": ["Zhang DM", "Zhang GY", "Wang T", "Zhong HJ", "Chen WK"], "date": "2006-05-16T00:00:00Z", "meta_date_publication": "2006 May 16", "meta_volume": "86", "meta_issue": "18", "meta_pages": "1279-83", "score": 50046.047, "text_hl": "The @<m>DISEASE_Lipoma</m> @DISEASE_MESH:D008067 @@@fatty degeneration@@@ grades of liver tissues of the @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ groups were grade: 0.8 +/- 0.3 and 1.0 +/- 0.2, both significantly lower than that of the @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NAFLD@@@ control group (grade 2.8 +/- 0.5, both P < 0.05). ", "citations": {"NLM": "Zhang DM, Zhang GY, Wang T, Zhong HJ, Chen WK. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats]. Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1279-83. PMID: 16796890", "BibTeX": "@article{16796890, title={[Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].}, author={Zhang DM and Zhang GY and Wang T and Zhong HJ and Chen WK}, journal={Zhonghua Yi Xue Za Zhi}, volume={86}, number={18}, pages={1279-83}}"}}, {"_id": "31512431", "pmid": 31512431, "title": "[The effect of high-dose metformin on the metabolic parameters and functional state of the liver of agouti-mice with the melanocortin obesity.]", "journal": "Adv Gerontol", "authors": ["Derkach KV", "Romanova IV", "Zorina II", "Bakhtyukov AA", "Perminova AA", "Ivantsov AO", "Shpakov AO"], "date": "2019-01-01T00:00:00Z", "meta_date_publication": "2019", "meta_volume": "32", "meta_issue": "3", "meta_pages": "431-438", "score": 50045.414, "text_hl": "At the same time, in the liver of Agouti line @SPECIES_10090 @@@mice@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@, the small-drop and large-drop @<m>DISEASE_Lipoma</m> @DISEASE_MESH:D008067 @@@fatty degeneration@@@ and the @DISEASE_Edema @DISEASE_MESH:D004487 @@@hydropic degeneration@@@ were attenuated, and the expression of pro-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ @GENE_IL1B @GENE_16176 @@@IL-1beta@@@ and pro-apoptotic @GENE_BAX @GENE_12028 @@@Bax@@@ protein and the @GENE_BAX @GENE_12028 @@@Bax@@@/@GENE_BCL2 @GENE_12043 @@@Bcl-2@@@ ratio did not differ from the control C57Bl/6J (a/a) @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Derkach KV, Romanova IV, Zorina II, Bakhtyukov AA, Perminova AA, Ivantsov AO, Shpakov AO. [The effect of high-dose metformin on the metabolic parameters and functional state of the liver of agouti-mice with the melanocortin obesity.] Adv Gerontol. 2019;32(3):431-438. PMID: 31512431", "BibTeX": "@article{31512431, title={[The effect of high-dose metformin on the metabolic parameters and functional state of the liver of agouti-mice with the melanocortin obesity.]}, author={Derkach KV and Romanova IV and Zorina II and Bakhtyukov AA and Perminova AA and Ivantsov AO and Shpakov AO}, journal={Adv Gerontol}, volume={32}, number={3}, pages={431-438}}"}}, {"_id": "9072666", "pmid": 9072666, "title": "[Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].", "journal": "Minerva Endocrinol", "authors": ["D'Argenzio R", "Cavallo P", "Merante D", "Morelli A"], "date": "1996-09-01T00:00:00Z", "meta_date_publication": "1996 Sep", "meta_volume": "21", "meta_issue": "3", "meta_pages": "101-10", "score": 50045.344, "text_hl": "@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@Glibenclamide@@@ stimulates @GENE_INS @GENE_3630 @@@insulin@@@ release by pancreatic beta cells (pancreatic attachment point), while @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ acts at a peripheral level by increasing @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ absorption in muscular, @<m>DISEASE_Lipoma</m> @DISEASE_MESH:D008067 @@@fatty@@@ and hepatic tissues, thus considerably reducing @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ (extra-pancreatic attachment point). ", "citations": {"NLM": "D'Argenzio R, Cavallo P, Merante D, Morelli A. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months]. Minerva Endocrinol. 1996 Sep;21(3):101-10. PMID: 9072666", "BibTeX": "@article{9072666, title={[Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].}, author={D'Argenzio R and Cavallo P and Merante D and Morelli A}, journal={Minerva Endocrinol}, volume={21}, number={3}, pages={101-10}}"}}, {"_id": "28127194", "pmid": 28127194, "pmcid": "PMC5236500", "title": "Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease", "journal": "World J Gastroenterol", "authors": ["Kostrzewski T", "Cornforth T", "Snow SA", "Ouro-Gnao L", "Rowe C", "Large EM", "Hughes DJ"], "date": "2017-01-14T00:00:00Z", "doi": "10.3748/wjg.v23.i2.204", "meta_date_publication": "2017 Jan 14", "meta_volume": "23", "meta_issue": "2", "meta_pages": "204-215", "score": 50041.38, "text_hl": "Hepatocytes, cultured under @<m>DISEASE_Lipoma</m> @DISEASE_MESH:D008067 @@@fatty@@@ conditions and treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, had a reduced cellular @GENE_FAT1 @GENE_2195 @@@fat@@@ content compared to untreated controls and consumed less @CHEMICAL_Fatty_Acids_Nonesterified @CHEMICAL_MESH:D005230 @@@FFA@@@ from cell culture medium.", "citations": {"NLM": "Kostrzewski T, Cornforth T, Snow SA, Ouro-Gnao L, Rowe C, Large EM, Hughes DJ. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease World J Gastroenterol. 2017 Jan 14;23(2):204-215. PMID: 28127194", "BibTeX": "@article{28127194, title={Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease}, author={Kostrzewski T and Cornforth T and Snow SA and Ouro-Gnao L and Rowe C and Large EM and Hughes DJ}, journal={World J Gastroenterol}, volume={23}, number={2}, pages={204-215}}"}}]}